MARKET

RGEN

RGEN

Repligen
NASDAQ
123.65
-1.67
-1.33%
After Hours: 123.65 0 0.00% 16:20 06/24 EDT
OPEN
124.71
PREV CLOSE
125.32
HIGH
129.11
LOW
123.55
VOLUME
891.70K
TURNOVER
0
52 WEEK HIGH
211.13
52 WEEK LOW
110.45
MARKET CAP
6.91B
P/E (TTM)
489.90
1D
5D
1M
3M
1Y
5Y
Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?
NASDAQ · 12h ago
Weekly Report: what happened at RGEN last week (0617-0621)?
Weekly Report · 15h ago
Top 3 Health Care Stocks That Could Blast Off In June
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its weakness. Repligen Corp. Has an RSI near or below 30.
Benzinga · 3d ago
Guggenheim Initiates Coverage of Repligen (RGEN) with Neutral Recommendation
NASDAQ · 5d ago
U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Aerovate Therapeutics, Boeing and Wingstop are among the companies. Boeing cuts its target price to $210 from $215. Aaron's Company, Abbvie and Chipotle Mexican Grill among those with positive reports.
Reuters · 6d ago
Repligen Initiated at Neutral by Guggenheim
Dow Jones · 6d ago
Guggenheim Initiates Coverage On Repligen with Neutral Rating
Benzinga · 6d ago
Repligen’s Strong Market Position and Strategic Leadership Transition Justify Buy Rating
TipRanks · 06/17 09:48
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.